Skip to content

Effect of curcumin on idiopathic chronic urticaria

Effect of curcumin on patients with idiopathic chronic urticaria: a triple blind clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240321061345N1
Enrollment
106
Registered
2024-04-30
Start date
2024-04-25
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

idiopathic chronic urticaria. Idiopathic urticaria

Interventions

Intervention 1: Intervention group: The desired intervention in this study is curcumin. In the intervention group, the usual treatment for urticaria + curcumin tablets will be taken orally with meals

Sponsors

Sanandaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients (male/female) aged 18 to 60 years with chronic idiopathic urticaria

Exclusion criteria

Exclusion criteria: Having underlying diseases allergy to turmeric obstruction of the gallbladder duct peptic ulcer Taking anticoagulant and antiplatelet drugs or Drugs used for high blood suger Patients have taken the previous urticaria treatment again after relapse. pregnancy

Design outcomes

Primary

MeasureTime frame
The score of the number of urticaria. Timepoint: The beginning of the study (before the start of the intervention)and every week after the start of the intervention for up to 6 months. Method of measurement: Checklist designed based on scoring.

Secondary

MeasureTime frame
Side effects of curcumin. Timepoint: The beginning of the study (before the start of the intervention)and every week after the start of the intervention for up to 6 months. Method of measurement: Checklist designed based on scoring.;The score of the size of urticaria. Timepoint: The beginning of the study (before the start of the intervention)and every week after the start of the intervention for up to 6 months. Method of measurement: Checklist designed based on scoring.;The score of itching intensity. Timepoint: The beginning of the study (before the start of the intervention)and every week after the start of the intervention for up to 6 months. Method of measurement: Checklist designed based on scoring.;Symptom duration score. Timepoint: The beginning of the study (before the start of the intervention)and every week after the start of the intervention for up to 6 months. Method of measurement: Checklist designed based on scoring.;Symptom recurrence score. Timepoint: The beginning of the study (before the start of the intervention)and every week after the start of the intervention for up to 6 months. Method of measurement: Checklist designed based on scoring.;Score of the frequency of antihistamine use. Timepoint: The beginning of the study (before the start of the intervention)and every week after the start of the intervention for up to 6 months. Method of measurement: Checklist designed based on scoring.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRasool Nasiri Kalmarzi

Sanandaj University of Medical Sciences

rasool_nsr@yahoo.com+98 87 3323 0524

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026